mannitol has been researched along with tacrolimus in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Balaji, V; Jurewicz, WA; Lord, R; Moore, R; Morris-Stiff, G; Ostrowski, K; Singh, J; Webley, Y | 1 |
| Siesjö, BK; Yoshimoto, T | 1 |
| Feng, XN; Xu, X; Zheng, SS | 1 |
| Gorur, SK; Haberal, M; Karakayali, FY; Moray, G; Sevmis, S | 1 |
2 review(s) available for mannitol and tacrolimus
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Current status and perspective of liver preservation solutions.
Topics: Adenosine; Allopurinol; Animals; Antibodies; Bile Duct Diseases; Disaccharides; Electrolytes; Fructosediphosphates; Glucose; Glutamates; Glutathione; Histidine; Humans; Insulin; Ischemia; Liver; Mannitol; Microcirculation; Organ Preservation Solutions; Potassium Chloride; Procaine; Raffinose; Tacrolimus; Transformation, Genetic; Tumor Necrosis Factor-alpha | 2006 |
1 trial(s) available for mannitol and tacrolimus
| Article | Year |
|---|---|
Preoperative induction with tacrolimus does not have a detrimental effect on primary graft function in adult cadaveric renal transplantation.
Topics: Adult; Azathioprine; Cadaver; Dopamine; Drug Administration Schedule; Furosemide; Humans; Immunosuppressive Agents; Kidney Transplantation; Mannitol; Methylprednisolone; Prospective Studies; Tacrolimus; Tissue Donors | 1998 |
4 other study(ies) available for mannitol and tacrolimus
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Posttreatment with the immunosuppressant cyclosporin A in transient focal ischemia.
Topics: Animals; Blood Glucose; Blood-Brain Barrier; Body Temperature; Brain Injuries; Carbon Dioxide; Carotid Arteries; Cyclosporine; Diuretics, Osmotic; Hydrogen-Ion Concentration; Immunosuppressive Agents; Infarction, Middle Cerebral Artery; Injections, Intra-Arterial; Ischemic Attack, Transient; Male; Mannitol; Osmosis; Oxygen; Rats; Rats, Wistar; Sodium Chloride; Tacrolimus; Wounds, Stab | 1999 |
Comparison of histidine-tryptophan-ketoglutarate and University of Wisconsin in living-donor liver transplantation.
Topics: Adenosine; Adult; Allopurinol; Female; Glucose; Glutathione; Humans; Immunosuppressive Agents; Insulin; Liver; Liver Diseases; Liver Transplantation; Living Donors; Male; Mannitol; Organ Preservation Solutions; Potassium Chloride; Procaine; Raffinose; Retrospective Studies; Tacrolimus | 2006 |